from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1829/-

LFCtreatmentdescriptionclass of inhibitor

-0.125

Amikacinug/mL Amikacintranslation

-0.048

Cap5-10ug/mL Capreomycintranslation

0.369

Rox10-50 ug/mL Roxithromycintranslation

-0.786

SM2-5 ug/mL Streptomycintranslation

0.440

Tet5-10 ug/mL Tetracyclinetranslation

-0.339

Rif0.2-5ug/mL Rifampicintranscription

-0.354

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.653

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.691

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.978

CPZ10-50 ug/mL Chlorpromazinerespiration

1.214

Clofazimine10-13 ug/mL Clofaziminerespiration

0.473

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.056

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.383

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.798

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.023

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.319

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.637

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.320

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.420

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.400

KCN5-20 ug/mL Potassium cyaniderespiration

-0.175

NaN30.2-2 mM Sodium aziderespiration

-0.878

Nigericin50 uM Nigericinrespiration

-0.257

TRC10-150 ug/mL Triclosanrespiration

1.442

TRZ10-25 ug/mL Thioridazinerespiration

-1.516

Valinomycin0.5-10 uM Valinomycinrespiration

-0.228

ZnSO42 mM ZnSO4respiration

0.382

menadione6-10 ug/mL Menadionerespiration

0.480

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.194

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.373

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.345

NRP_1Non-replicating persistence stage 1dosRassociated

0.006

Amp0.2mg/mL AmpicillincellWall

-0.131

Cephalexin20-100 ug/mL CephalexincellWall

-0.562

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.271

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.012

EMB10-20 ug/mL EthambutolcellWall

0.305

Eta12-40 ug/mL EthionamidecellWall

-0.022

INH0.2-0.4 ug/mL IsoniazidcellWall

0.328

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.430

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.168

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.923

BZA0.12 mg/mL BenzamidearomaticAmides

-0.874

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.056

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.852

H2O24 mM hydrogen peroxideDNAdamaging

-0.761

Levo10 ug/mL LevofloxacinDNAdamaging

-0.277

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.476

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.381

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.464

UVUV-irradiationDNAdamaging

0.181

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.160

Antimycin12.5-50 ug/mL Antimycin A?

-0.212

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.063

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.077

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.906

PA8240.2-2 ug/mL PA-824?

-0.434

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.698

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.805

Verapamil50 uM Verapamil?

-0.245

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.317

methoxatin10-20 ug/mL Methoxatin?